Cargando…
Opinion: An Existing Drug to Assess In Vivo for Potential Adjunctive Therapy of Ebola Virus Disease and Post-Ebola Syndrome
Autores principales: | Hendricks, Katherine, Parrado, Meredith Gilman, Bradley, John |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7002323/ https://www.ncbi.nlm.nih.gov/pubmed/32082173 http://dx.doi.org/10.3389/fphar.2019.01691 |
Ejemplares similares
-
Sofosbuvir: A Potential Treatment for Ebola
por: Reznik, Sandra E., et al.
Publicado: (2018) -
Ebanga™: The most recent FDA-approved drug for treating Ebola
por: Taki, Elahe, et al.
Publicado: (2023) -
Discovering Drugs for the Treatment of Ebola Virus
por: Bixler, Sandra L., et al.
Publicado: (2017) -
Ebola Virus Persistence in Semen Ex Vivo
por: Fischer, Robert J., et al.
Publicado: (2016) -
Post-Ebola Syndrome among Ebola Virus Disease Survivors in Montserrado County, Liberia 2016
por: Wilson, Himiede W., et al.
Publicado: (2018)